Nuo Therapeutics (AURX) Return on Sales [ROS] (2010 - 2026)
Nuo Therapeutics' Return on Sales [ROS] was -9.42% in Q2 2026, up 83.70 percentage points from -93.12% a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nuo Therapeutics' Return on Sales [ROS] was -42.15% through Jun 30, 2026, up 91.35 percentage points year-over-year; for FY2025, it was -75.95%, up 104.09 percentage points from FY2024.
- Return on Sales [ROS] has now increased for three consecutive years, with a three-year change of +2882.26 percentage points (FY2022 to FY2025).
- In earlier years, Return on Sales [ROS] was -180.04% in FY2024 (+340.61 pp), -520.65% in FY2023 (+2437.56 pp) and -2958.21% in FY2022.
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q3 2020.
- Over the past five years, the year-over-year gain in Return on Sales [ROS] ranged from 55.46 percentage points (Q2 2025) to 2043.99 percentage points (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 248.22 Bn | 227.25 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 178.33 Bn | 148.76 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 159.74 Bn | 143.54 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 158.45 Bn | 138.74 Bn | 2.08 Bn | 19.44% |
| 5 | Medtronic | 122.77 Bn | 88.02 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 118.25 Bn | 104.37 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 66.98 Bn | 61.75 Bn | 3.85 Bn | 21.65% |
| 8 | Becton Dickinson | 54.49 Bn | 51.64 Bn | 2.32 Bn | 13.31% |
| 9 | Edwards Lifesciences | 51.67 Bn | 35.68 Bn | 1.35 Bn | 29.48% |
| 10 | Nuo Therapeutics | 62.93 Mn | 61.10 Mn | 1.17 Mn | -9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.42% |
| Dec 31, 2025 | -52.82% |
| Sep 30, 2025 | -52.33% |
| Jun 30, 2025 | -93.12% |
| Mar 31, 2025 | -153.83% |
| Dec 31, 2024 | -159.35% |
| Sep 30, 2024 | -155.65% |
| Jun 30, 2024 | -148.58% |
| Mar 31, 2024 | -302.35% |
| Dec 31, 2023 | -330.99% |
| Sep 30, 2023 | -339.97% |
| Jun 30, 2023 | -737.44% |
| Mar 31, 2023 | -1,399.66% |
| Dec 31, 2022 | -1,301.60% |
| Sep 30, 2022 | -2,383.96% |
| Sep 30, 2020 | 394.84% |
| Jun 30, 2020 | -20.85% |
| Mar 31, 2020 | -373.77% |
| Dec 31, 2019 | 1,505.55% |
| Sep 30, 2019 | -66.85% |
API Access
Nuo Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();